CJC-1295 vs Ipamorelin
The search is 'vs' but the real-world relationship is 'and' — these two are the textbook peptide pairing, each pushing a different button.
Side by side
| CJC-1295 | Ipamorelin | |
|---|---|---|
| Class | Peptides | Peptides |
| Form | Injection | Injection |
| Half-life | ≈ 30 minutes | ≈ 2 hours |
| Storage | — | — |
| Dose units | mcg, mg | mcg, mg |
| FDA status | Not FDA-approved | Not FDA-approved |
Facts from the Stack compound library. See the full pages: CJC-1295 (no DAC) · Ipamorelin.
How they differ
Mechanism
CJC-1295 mimics GHRH. Ipamorelin mimics ghrelin and is prized for being selective (it raises GH with comparatively little effect on other hormones). Two different signals, often used together.
Why they're stacked
Because they act on separate receptors, they're frequently logged as a pair on the same schedule. Stack groups them under one protocol you can pause together.
DAC vs no-DAC
CJC-1295 comes with and without DAC (drug affinity complex), which dramatically changes its half-life and dosing cadence — see the separate library entries. Ipamorelin is short-acting.
Handling
Both are reconstituted peptides, typically refrigerated. The same vial math and opened-date tracking apply to each.
Tracking either one
Whichever you log, the workflow is the same in Stack: add it once, set the schedule, and let the app handle reminders, supply projection and an "in your system" curve from the half-life. Run both? Group them into one protocol you can pause together.
Track your stack in Stack
Free, private, no account. Doses, schedules, supply and trends in one quiet app.
Get the appLast reviewed 2026-06-11